3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Breast
15
Gastrointestinal
3
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Conditions
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Anus Neoplasms
1
Adenocarcinoma
1
Interventions
Blood Specimen Collection
14
Surveys and Questionnaires
13
Surgical Procedures, Operative
12
Gene Expression Profiling
10
Observation
7
Amplified Fragment Length Polymorphism Analysis
7
Polymerase Chain Reaction
6
Drug Therapy
6
Radiotherapy
5
Microarray Analysis
5
Immunohistochemistry
5
Psychiatric Rehabilitation
4
Imatinib Mesylate
4
Base Sequence
4
regorafenib
3
Trabectedin
3
Tissue Banks
3
Therapeutics
3
Sunitinib
3
Specimen Handling
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Methods
3
Magnetic Resonance Imaging
3
Interviews as Topic
3
Doxorubicin
3
Biopsy
3
ripretinib
2
mifamurtide
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
trastuzumab deruxtecan
×
Sarcoma
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled